Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2005
09/01/2005WO2005080399A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
09/01/2005WO2005080398A1 Method for the production of anagrelide hydrochloride
09/01/2005WO2005080397A2 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
09/01/2005WO2005080396A2 Azolopyrimidine compounds and use thereof for combating parasitic fungi
09/01/2005WO2005080393A1 Compounds and compositions as protein kinase inhibitors
09/01/2005WO2005080391A1 Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
09/01/2005WO2005080388A1 Viral polymerase inhibitors
09/01/2005WO2005080372A1 Dihydropyridinone derivatives
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080359A1 Benzamide derivatives and their use as glucokinae activating agents
09/01/2005WO2005080356A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
09/01/2005WO2005080355A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
09/01/2005WO2005080352A2 Quinazoline derivatives and therapeutic use thereof
09/01/2005WO2005080348A1 Novel sulfone amide derivative
09/01/2005WO2005080334A1 Novel heterocyclic compound
09/01/2005WO2005079868A2 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses
09/01/2005WO2005079805A1 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
09/01/2005WO2005079574A1 Bicyclic melanocorin-specific compounds
09/01/2005WO2005042533A3 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
09/01/2005WO2005000197A3 Selective serine/threonine kinase inhibitors
09/01/2005US20050192418 Heterocyclic metallocenes and polymerization catalysts
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192310 Fused heterotricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
09/01/2005US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity
09/01/2005US20050192278 Pyridazino[6,1-c ][1,2,4]triazin-4-ones; mediate physiological and psychotropic effects; antagonists; antiemetics;
09/01/2005US20050192253 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
09/01/2005DE102004001457A1 Verfahren zur Herstellung von Phthaloxyaninen A process for preparing Phthaloxyaninen
09/01/2005CA2557433A1 Quinazoline derivatives and therapeutic use thereof
09/01/2005CA2556350A1 Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
09/01/2005CA2556320A1 Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists for the treatment of gastrointestinal disorders
09/01/2005CA2556263A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2555409A1 Novel sulfone amide derivative
09/01/2005CA2555263A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
09/01/2005CA2555084A1 Combinatorial therapy with an acetylcholinesterase inhibitor and (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate
09/01/2005CA2555071A1 Histamine-3 receptor modulators
09/01/2005CA2554774A1 Novel heterocyclic compound
09/01/2005CA2554310A1 Benzamide derivatives and their use as glucokinase activating agents
08/2005
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1567528A1 Mixed lineage kinase modulators
08/31/2005EP1567527A1 Condensed pyrazolo derivatives
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005EP1430057B1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
08/31/2005EP1417207B1 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin-7-ones
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1368579A4 Synthetic molecular spring device
08/31/2005EP1347978B1 Novel substituted imidazotriazinones as pde ii-inhibitors
08/31/2005EP1289963B1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662538A Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662537A Pyrazolo (1, 5-a) pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
08/31/2005CN1662531A Hetero-bicyclic compounds
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662494A Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1660921A High heat resistant carbonate polymers and its prepn.
08/31/2005CN1660853A Indolecarboxylic ester trimer and electrochemical cell using the same
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660808A Method for continuous extracting chlorophyll and isoflavone from haulm of liquorice and application
08/31/2005CN1660033A Composition for dyeing keratinous fibers comprising at least one diamino-n, n-dihydropyrazolone derivative
08/31/2005CN1217231C Color potographic silver halides sensitive material, pyrrolotriazole compound and color forming compound
08/30/2005US6936632 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
08/30/2005US6936631 Bicyclic imidazo-5-yl-amine derivatives
08/30/2005US6936619 Quinazolinone compounds useful in therapy
08/30/2005US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
08/30/2005US6936609 Hydrolase enzyme inhibitors comprising nitrogen compounds such as 2-(3,4-Dimethoxyphenyl)-7-(1-ethylpropyl)-5-methyl-4-(3,4,5-trimethoxyphenoxy)-imidazo[5,1-f][1,2,4]triazine, used for prophylaxis of neurodegenerative disorders
08/30/2005US6936608 7-phenylimidazo(1,2-b)(1,2,4)triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a
08/30/2005US6936604 Treating hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis and water retention
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/25/2005WO2005078805A1 Organic thin film transistor
08/25/2005WO2005077956A1 Substituted sym-triindole
08/25/2005WO2005077955A1 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics
08/25/2005WO2005077954A2 Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
08/25/2005WO2005077953A1 Nitrogenous fused heteroaromatic ring derivative
08/25/2005WO2005077952A1 Imidazolopyrimidines used as fungicidal active ingredients
08/25/2005WO2005077951A2 7h-pyrrolopyrimidine derivatives
08/25/2005WO2005077940A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use
08/25/2005WO2005077363A1 Heterocyclic gaba-a subtype selective receptor modulators
08/25/2005WO2005077269A1 Substituted porphyrins
08/25/2005WO2005063767A3 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
08/25/2005WO2005063764A3 Fused pyrrolocarbazoles and methods for the preparation thereof
08/25/2005WO2005042534A3 A2b adenosine receptor antagonists
08/25/2005WO2005021515A3 Inhibitors of phosphodiesterase type-iv
08/25/2005US20050187390 Bicyclic heteroaryl derivatives
08/25/2005US20050187389 Pyrrolo[2,3-d]pyrimidine derivatives; inhibitors of protein tyrosine kinase activity especially modulators of epidermal growth factor receptor; antiproliferative; anticancer; blood vessel growth, benign hyperplasia, keloid formation, psoriasis; (1-Phenylethyl)-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine
08/25/2005US20050187231 4-aminoquinazolines e.g. 4-(4-phenylbutylamino)quinazoline; antiproliferative agents; antitumor agents; hyperproliferative disorders, including tumors, such as breast, brain, and kidney tumors
08/25/2005US20050187225 dissolving in solvent; precipitation; isolation; sleep disorders; sedatives; antiepileptic agents
08/25/2005US20050187224 Pyrazolopyrimidines
08/25/2005US20050187223 Antiinflammatory agents; rheumatic diseases;Paget's disease; leukemia; inflammatory bowel disorders; adult respiratory distress syndrome; antiallergens; Alzheimer's disease;%
08/25/2005US20050187219 Pyrazolotriazines as kinase inhibitors
08/25/2005US20050187206 Novel crystalline forms of temozolomide
08/25/2005US20050187110 Novel herbicides
08/25/2005US20050186173 Biocidal siloxane coating material containing N-halogenated amine and amide functional groups
08/25/2005US20050185247 Indolecarboxylic ester trimer and electrochemical cell using the same
08/25/2005DE10339629B4 Process to encapsulate an organic electronic component with a layer of hydrophobic, linear or two-dimensional polycyclic aromatic material
08/25/2005DE10301788B4 Pharmazeutische Verwendung von Pyrimido[5,4-e][1,2,4]triazin-5,7-dionen Pharmaceutical use of pyrimido [5,4-e] [1,2,4] triazine-5,7-diones
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 573